SCHEMBL667571

SCHEMBL667571

N[C@@H]1C[C@H]1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL296233 1.00
SCHEMBL31520043 1.00
SCHEMBL4037202 1.00
SCHEMBL9512745 1.00
SCHEMBL31520046 1.00
SCHEMBL5844291 0.97 GABRR1 (0.94)
SCHEMBL24293602 0.83 GABRR1 (0.70)
SCHEMBL4858169 0.81
SCHEMBL5028910 0.81
SCHEMBL17234168 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4103734-A2 LONG CHAIN CARBON AND CYCLIC AMINO ACIDS SUBSTRATES FOR GENETIC CODE REPROGRAMMING Northwestern University (US) 2022-12-21 EP disclosed
US-11266968-B2 Mineralizing biosurfactant used for nucleating silica THE UNIVERSITY OF QUEENSLAND (AU) 2022-03-08 US disclosed
EP-3046870-B1 SILICA MICRO- AND NANO-CAPSULES AND METHODS FOR MAKING THEM UNIV QUEENSLAND (AU) 2021-08-11 EP disclosed
EP-2861217-B1 NANOEMULSIONS UNIV QUEENSLAND (AU) 2017-09-06 EP disclosed
US-20170188618-A1 STABLE EMULSIONS FROM DIPEPTIDE DERIVATIVES UNIVERSITY OF STRATHCLYDE (GB) 2017-07-06 US disclosed
EP-3145335-A1 STABLE EMULSIONS University of Strathclyde (GB) 2017-03-29 EP disclosed
US-9554995-B2 Nanoemulsions THE UNIVERSITY OF QUEENSLAND (AU) 2017-01-31 US disclosed
CN-105968029-A Trans-2-amino-cyclopropyl formic acid derivative and synthetic method thereof 南京富润凯德生物医药有限公司 2016-09-28 CN disclosed
CN-105968029-A Trans-2-amino-cyclopropyl formic acid derivative and synthetic method thereof 南京富润凯德生物医药有限公司 2016-09-28 CN disclosed
US-20160193581-A1 SILICA MICRO- AND NANO-CAPSULES AND METHODS FOR MAKING THEM THE UNIVERSITY OF QUEENSLAND (AU) 2016-07-07 US disclosed
WO-2012142659-A1 SITE-SELECTIVE MODIFICATION OF PROTEINS BAKER IDI HEART AND DIABETES INSTITUTE HOLDINGS LIMITED (AU) 2012-10-26 WO disclosed
US-20120046444-A1 PEPTIDE NETWORKS THE UNIVERSITY OF QUEENSLAND (AU) 2012-02-23 US disclosed
US-8039582-B2 Peptide networks THE UNIVERSITY OF QUEENSLAND (AU) 2011-10-18 US disclosed
WO-2011116411-A1 SALT-RESISTANT EMULSIONS PEPFACTANTS PTY LTD (AU) 2011-09-29 WO disclosed
US-20100152420-A1 PEPTIDE NETWORKS THE UNIVERSITY OF QUEENSLAND (AU) 2010-06-17 US disclosed
EP-0460679-B1 Endothelin antagonistic peptide derivatives BANYU PHARMA CO LTD (JP) 1998-10-28 EP disclosed
US-5691315-A CARDIOVASCULAR DISORDERS; VASODILATOR; BRONCHODILATOR BANYU PHARMACEUTICAL CO., LTD. (JP) 1997-11-25 US disclosed
US-5470833-A Vasodilators, bronchodilators BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-11-28 US disclosed
US-5444152-A Vasolidator or bronchodilator BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-22 US disclosed
EP-0460679-A2 Endothelin antagonistic peptide derivatives Banyu Pharmaceutical Co., Ltd. (JP) 1991-12-11 EP disclosed